-
Something wrong with this record ?
The oriented development of antituberculotics: salicylanilides
Waisser K, Matyk J, Divisová H, Husáková P, Kunes J, Klimesová V, Kaustová J, Möllmann U, Dahse HM, Miko M.
Language English Country Germany
NLK
Wiley Online Library (archiv)
from 1996-01-01 to 2012-12-31
- MeSH
- Antitubercular Agents pharmacology chemical synthesis chemistry MeSH
- Financing, Organized MeSH
- Microbial Sensitivity Tests MeSH
- Mycobacterium avium drug effects MeSH
- Mycobacterium kansasii drug effects MeSH
- Mycobacterium tuberculosis drug effects MeSH
- Salicylanilides pharmacology chemical synthesis chemistry MeSH
- Structure-Activity Relationship MeSH
On the basis of our previous results 22 salicylanilides were synthesized. The compounds were tested for in vitro antimycobacterial activity against Mycobacterium tuberculosis, Mycobacterium kansasii, and Mycobacterium avium. The Free-Wilson method was used to evaluate structure-antimycobacterial activity relationships. 4-Chloro-N-(4-propylphenyl)salicylamide and 5-chloro-N-(4-propylphenyl)salicylamide were selected for preclinical studies.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07524060
- 003
- CZ-PrNML
- 005
- 20111210140709.0
- 008
- 090528s2006 gw e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Waisser, Karel, $d 1936-2017 $7 jn20000402669
- 245 14
- $a The oriented development of antituberculotics: salicylanilides / $c Waisser K, Matyk J, Divisová H, Husáková P, Kunes J, Klimesová V, Kaustová J, Möllmann U, Dahse HM, Miko M.
- 314 __
- $a Department of Inorganic and Organic Chemistry, Charles University in Prague, Faculty of Pharmacy, Hradec Králové, Czech Republic. waisser@faf.cuni.cz
- 520 9_
- $a On the basis of our previous results 22 salicylanilides were synthesized. The compounds were tested for in vitro antimycobacterial activity against Mycobacterium tuberculosis, Mycobacterium kansasii, and Mycobacterium avium. The Free-Wilson method was used to evaluate structure-antimycobacterial activity relationships. 4-Chloro-N-(4-propylphenyl)salicylamide and 5-chloro-N-(4-propylphenyl)salicylamide were selected for preclinical studies.
- 650 _2
- $a antituberkulotika $x farmakologie $x chemická syntéza $x chemie $7 D000995
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a Mycobacterium avium $x účinky léků $7 D009162
- 650 _2
- $a Mycobacterium kansasii $x účinky léků $7 D019909
- 650 _2
- $a Mycobacterium tuberculosis $x účinky léků $7 D009169
- 650 _2
- $a salicylanilidy $x farmakologie $x chemická syntéza $x chemie $7 D012458
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Matyk, Josef. $7 _AN029820
- 700 1_
- $a Divišová, Hana $7 xx0128509
- 700 1_
- $a Husáková, Petra. $7 _AN026193
- 700 1_
- $a Kuneš, Jiří, $d 1965- $7 xx0105105
- 700 1_
- $a Klimešová, Věra, $d 1952- $7 jk01060593
- 700 1_
- $a Kaustová, Jarmila $7 xx0081391
- 700 1_
- $a Möllmann, Ute
- 700 1_
- $a Dashe, Hans-Martin
- 700 1_
- $a Miko, Milan, $d 1935- $7 mzk2004261224
- 773 0_
- $w MED00000507 $t Archiv der Pharmazie $g Roč. 339, č. 11 (2006), s. 616-620 $x 0365-6233
- 910 __
- $a ABA008 $b x $y 9
- 990 __
- $a 20090519102933 $b ABA008
- 991 __
- $a 20111007112918 $b ABA008
- 999 __
- $a ok $b bmc $g 659607 $s 515018
- BAS __
- $a 3
- BMC __
- $a 2006 $b 339 $c 11 $d 616-620 $i 0365-6233 $m Archiv der Pharmazie $x MED00000507
- LZP __
- $a 2009-B2/dkme